Image credit: Alyson Martin

SAMHSA: Newly Popular Cannabis Compounds Are Complicating Impairment Testing

The FDA’s work on CBD, a drop in military members testing positive for cannabis, and other cannabis-related topics were on the agenda at a federal Drug Testing Advisory Board meeting this week.

Research
Equity

Cannabis Regulators of Color Coalition Pushes Back On Banking-As-Equity Narrative

The group of panelists, hosted by The Ohio State University Moritz College of Law Drug Enforcement and Policy Center, proposed amendments to the SAFE Banking Act.

New York

New York Regulators Approve Cannabis Processors, Expedite Lab Testing

Regulators also put forward a leader at cannabis data company New Frontier as Director of Policy.